Jenny Tan
Impact in
- Hepatology top 2%
- Liver physiology and pathology
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
Papers in
-
- Nitric Oxide and Endothelin Effects 3
- Adenosine and Purinergic Signaling 3
-
- Carbohydrate Chemistry and Synthesis 11
- Co-authors
- Harry SchachterF. Michael YakesAlison JolyFawn QianFrauke BentzienToshihiro YamaguchiStefan EngstPeiwen Yu
- Journals
- Bioorganic & Medicinal Chemistry Letters (7 papers)Journal of Medicinal Chemistry (6 papers)European Journal of Biochemistry (4 papers)Clinical Genetics (2 papers)International Journal of Paediatric Dentistry (2 papers)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Jenny Tan
46 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Hepatology 362
- Oncology 648
- Organic Chemistry 544
- Molecular Biology 1.3k
- Cancer Research 246
Countries citing papers authored by Jenny Tan
This map shows the geographic impact of Jenny Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny Tan more than expected).
Fields of papers citing papers by Jenny Tan
This network shows the impact of papers produced by Jenny Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny Tan. The network helps show where Jenny Tan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jenny Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2021 | 2 | |
| 3 | 2021 | 6 | |
| 4 | Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth Hit paper breakdown → | 2011 | 1036 |
| 5 | 2011 | 8 | |
| 6 | 2009 | 282 | |
| 7 | 2008 | 57 | |
| 8 | 2006 | 29 | |
| 9 | 2005 | 55 | |
| 10 | 2005 | 68 | |
| 11 | 2002 | 32 | |
| 12 | 2001 | 111 | |
| 13 | 2000 | 15 | |
| 14 | 1998 | 7 | |
| 15 | 1997 | 26 | |
| 16 | 1997 | 14 | |
| 17 | 1994 | 69 | |
| 18 | 1991 | 10 | |
| 19 | 1990 | 16 | |
| 20 | 1989 | 25 |
About Jenny Tan
Jenny Tan is a scholar working on Physiology, Organic Chemistry, Molecular Biology, Nutrition and Dietetics and Emergency Medical Services, having authored 46 papers that have together received 2.5k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (12 papers), Carbohydrate Chemistry and Synthesis (11 papers), Peptidase Inhibition and Analysis (4 papers), Nitric Oxide and Endothelin Effects (3 papers), Adenosine and Purinergic Signaling (3 papers), Liver physiology and pathology (2 papers), Lipoproteins and Cardiovascular Health (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Hepatology (362 citations), Oncology (648 citations), Organic Chemistry (544 citations), Molecular Biology (1.3k citations) and Cancer Research (246 citations). Jenny Tan has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Harry Schachter, F. Michael Yakes, Alison Joly, Fawn Qian, Frauke Bentzien, Toshihiro Yamaguchi, Stefan Engst, Peiwen Yu, Jason Chen and Lillian Lee. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, European Journal of Biochemistry, Clinical Genetics and International Journal of Paediatric Dentistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.